Bridging the Gap Between Basic Research and Industrial Application
Professor Dr Pierre Jacobs, KU Leuven (Belgium), has received the BASF-DECHEMA Alwin Mittasch Special Prize for his research into materials and their use as process catalysts. The award, which comes with €10,000 in prize money, was presented at the “Future Loves History — 100 Years of Ammonia Synthesis” scientific symposium at BASF in Ludwigshafen.
“Professor Jacobs has succeeded in a special way in spanning the bridge between basic research and industrial application,” said Professor Rainer Diercks, President Petrochemicals BASF and Chairman of DECHEMA. Initially focusing on zeolites and their use in catalysis, Pierre Jacobs gradually expanded his research activities to include other heterogeneous and homogeneous catalytic processes. Many of his research insights are now in industrial use. These include synthesis of g-butyrolactone from maleic acid anhydride, an important step in the manufacture of anti-dementia drugs, and side chain alkylation of alkyl-substituted anthraquinones, an intermediate step in industrial hydrogen peroxide production. His research areas also include catalytic processing of biomass.
DECHEMA confers the Alwin Mittasch Prize usually every 3 years. This year BASF sponsored a special prize to mark the 100th anniversary of the commissioning of the first ammonia plant in September 1913. “Without the enormous efforts of catalyst research, the Haber-Bosch process for ammonia production would never have been transferred to industrial scale and this world would be a different place,” Dr Peter Schuhmacher, President Process Research and Chemical Engineering said. “For that reason, it was a matter of great importance to us to present the award to someone who is continuing Alwin Mittasch’s legacy.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance